By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance In U.S. For Psoriasis Patent 2/17/2015 8:53:50 AM
Can-Fite BioPharma (CFBI) Completes Phase 2/3 Trial For CF101 In Treatment of Psoriasis 2/4/2015 7:26:38 AM
Can-Fite BioPharma (CFBI)'s CF602 Demonstrates Efficacy In Treatment Of Sexual Dysfunction In Preclinical Studies 1/27/2015 7:29:41 AM
Can-Fite BioPharma (CFBI) Announces Upcoming 2015 Clinical Milestones For Its Pipeline Of Drugs In 4 Indications 1/6/2015 7:29:30 AM
Can-Fite BioPharma (CFBI) Completes The Design Of The Rheumatoid Arthritis Phase 3 Study Of Its Lead Drug Candidate Cf101 12/30/2014 7:23:58 AM
Can-Fite BioPharma (CFBI) Doses First Patient In Global Phase 2 Liver Cancer Trial For CF102 12/22/2014 7:51:41 AM
Can-Fite BioPharma (CFBI) Release: Second Part Of The Glaucoma Phase 2 Study Has Been Approved In A European Country 12/15/2014 7:42:18 AM
Can-Fite BioPharma (CFBI) To Initiate The Development Program Of Its Next Generation Drug Cf602 12/9/2014 7:36:12 AM
Can-Fite BioPharma (CFBI) Announces $8 Million At-The-Market Registered Direct Offering 12/2/2014 2:28:46 PM
Can-Fite BioPharma (CFBI) Reports Financial Results For Nine Months Ended September 30, 2014 12/2/2014 10:57:59 AM